Useful Links: Adverse Events Reporting and Medical enquiries
UK/FLU/0718/0053c July 2018 © Seqirus UK Limited. This awareness site has been developed by Seqirus UK Limited |
FOR UK HEALTHCARE PROFESSIONALS ONLY
This section is intended for healthcare professionals and associated healthcare employees who are involved in patient care or service provision for influenza immunisation in the UK only – this includes (but is not limited to) GPs, nurses, practice managers, pharmacists, and pharmacy counter assistants.I AM A HEALTHCARE PROFESSIONAL OR ASSOCIATED HEALTHCARE EMPLOYEE I AM NOT A HEALTHCARE PROFESSIONAL OR ASSOCIATED HEALTHCARE EMPLOYEE
In July 2015, bioCSL and the influenza vaccines of Novartis joined forces to create Seqirus, now the second largest influenza vaccine company in the world.
With extensive research and production expertise and manufacturing plants in the US, UK, Germany and Australia, Seqirus is a transcontinental partner in pandemic preparedness and a major contributor to the prevention and control of influenza globally.
Seqirus is committed to improving public health by assuring the quality, safety and efficacy of influenza vaccines.
If you would like further information on Seqirus UK Limited, please contact your Seqirus Account Manager or Customer Services:
Telephone: 0845 745 1500